Showing results (31-40 of 60) with videos related to
Sort By:
Pageof 6
The Journal of Investigative Dermatology|July 19, 2022
Cutaneous Lymphocyte Antigen Is a Potential Therapeutic Target in Cutaneous T-Cell LymphomaSara Peru, Martina Prochazkova-Carlotti, Floriane Cherrier, et al.Plos One|March 17, 2017
TP53 alterations in primary and secondary Sézary syndrome: A diagnostic tool for the assessment of malignancy in patients with erythrodermaAudrey Gros, Elodie Laharanne, Marie Vergier, et al.Journal of the American Academy of Dermatology|January 29, 2022
Real-life impact of immunologic tests to predict relapse after treatment cessation in patients with bullous pemphigoid: A French multicenter retrospective studyGilles Battesti, Charline Garcia, Manuelle Viguier, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 28, 2018
Double-hit or dual expression of MYC and BCL2 in primary cutaneous large B-cell lymphomasSarah Menguy, Eric Frison, Martina Prochazkova-Carlotti, et al.Blood Advances|December 8, 2025
Cutaneous diffuse large B-cell lymphoma induces a macrophage immunosuppressive phenotype through IL-10 secretionJean Galtier, Rémi Peanne, Valérie Le Morvan, et al.Blood|January 29, 2014
Telomerase functions beyond telomere maintenance in primary cutaneous T-cell lymphomaEdith Chevret, Laetitia Andrique, Martina Prochazkova-Carlotti, et al.Melanoma Research|February 7, 2023
Drug reactions with eosinophilia and systemic symptoms induced by immune checkpoint inhibitors: an international cohort of 13 casesSaskia Ingen-Housz-Oro, Brigitte Milpied, Benoit Bensaid, et al.Molecular Oncology|March 14, 2021
Exploring hTERT promoter methylation in cutaneous T-cell lymphomasAlain Chebly, Joana Ropio, Jean-Marie Peloponese, et al.Joint Bone Spine|October 24, 2024
Resolution of immune checkpoint inhibitors-induced inflammatory arthritis while maintaining active treatment with checkpoint inhibitors and after its discontinuation: An observational studyAlexandra Ladouceur, Thomas Barnetche, Sorilla Prey, et al.Annals of the Rheumatic Diseases|November 18, 2017
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort studyMarie Kostine, Léa Rouxel, Thomas Barnetche, et al.Pageof 6